Search results for " education"
Webcast
Principles of Cell Line Development
This free online course provides an overview of how cell line development plays a critical role in a biotherapeutic drug’s path to market.
Webcast
e-Learning: what is quality by design (QbD)
This free interactive course shares what quality by design (QbD) is all about. The focus lies on applying QbD to process development of biopharmaceuticals.
Article
Maximum Output Starts with Optimized Upstream Processing
KBI Biopharma is tackling this problem by working closely with educational institutions and large industry networks to create a sustainable workforce to support its growth. Lipinski observes that the …
Article
Genetic Vaccine Platforms Demonstrate Their Potential
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
By Cynthia A. Challener
For a vaccine to be effective, the components of the disease o…
Article
Biopharma Seeks Balance
Now that personalized therapies have arrived, the biopharma industry must adopt new development processes, delivery methods, processing steps, and pricing schemes, and expand patient and physician edu…
Article
The New World of Biopharmaceutical Manufacturing
We must drive continuous improvement in education, standardization, and technology. Industry stakeholders (e.g., suppliers, users, regulators) must continue to exchange expertise and knowledge. Collab…
Article
Mechanistic Modeling of Preparative Ion-Exchange Chromatography
By Anurag Rathore, Vijesh Kumar
Among the various downstream processing unit operations that are used for purification of biotech products, chromatography is uniquely capable of providing resolu…
Article
Advancing Single-Use Technology Through Collaboration
By working together to harmonize the highly variable steps within the biopharmaceutical manufacturing process, both end users and suppliers are making strides toward the efficiency and integrity of …
Article
Biosimilars: Making the Switch Comes with Challenges
In this respect, education of physicians and other stakeholders about the advantages of biosimilars had become a crucial factor.
There have been sharp differences between, and even within, countri…
Article
Framing Biopharma Success in 2016
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.
By Rita C. Peters
The US biopharmaceutical industry turned a new page in 2015 when…